NR
PODD icon

Newfound Research’s Insulet PODD Stock Holding History

Newfound Research’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-327
Closed -$87K – 145
2021
Q4 		$87K Buy
+327
New +$94.9K 0.11% 104
2021
Q2 		– Sell
-248
Closed -$65K – 126
2021
Q1 		$65K Sell
248
-6
-2% -$1.61K 0.15% 86
2020
Q4 		$65K Buy
254
+120
+90% +$29.8K 0.17% 97
2020
Q3 		$32K Buy
+134
New +$28.2K 0.09% 74

Other funds holding PODD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DCP
D1 Capital Partners New York $34.8B AUM 11.34% 1-Year Est. Return

Newfound Research's PODD Position: Q1 2022 in Review

Newfound Research sold out of Insulet (PODD) in Q1 2022, closing a stake of 327 shares — an estimated $87K sold.

Newfound Research first reported a position in PODD in Q3 2020 and held it in 4 quarters. The position peaked at $87K in Q4 2021. 483 funds tracked by Wall St. Rank hold PODD as of Q1 2022.

  • Newfound Research reported no remaining Insulet position as of Q1 2022 after selling out during the quarter.
  • Newfound Research sold 327 Insulet shares in Q1 2022, an estimated $87K.
  • Newfound Research first reported a position in Insulet in Q3 2020 and held it in 4 quarters.
  • Newfound Research's Insulet position peaked at $87K in Q4 2021.
  • 483 funds tracked by Wall St. Rank held Insulet as of Q1 2022.

Based on Newfound Research's 13F filing for Q1 2022, filed 4 May 2022.